Search

Your search keyword '"Correll, Christoph U"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Correll, Christoph U" Remove constraint Author: "Correll, Christoph U" Journal journal of clinical psychiatry Remove constraint Journal: journal of clinical psychiatry
138 results on '"Correll, Christoph U"'

Search Results

19. How to Interpret Findings Concerning Newly Approved Antipsychotic Agents: Clinical Implications of the Lurasidone PEARL 2 Study.

20. Are Antipsychotics or Antidepressants Needed for Psychotic Depression? A Systematic Review and Meta-Analysis of Trials Comparing Antidepressant or Antipsychotic Monotherapy With Combination Treatment.

21. Prediabetes in Patients Treated With Antipsychotic Drugs.

22. What Are We Looking for in New Antipsychotics?

23. Mid-Term and Long-Term Efficacy and Effectiveness of Antipsychotic Medications for Schizophrenia: A Data-Driven, Personalized Clinical Approach.

24. QT Interval Duration and Dispersion in Children and Adolescents Treated With Ziprasidone.

25. Developments in Pediatric Psychopharmacology: Focus on Stimulants, Antidepressants, and Antipsychotics.

26. Determinants of Poor Dental Care in Patients With Schizophrenia: A Historical, Prospective Database Study.

27. Past and Present Progress in the Pharmacologic Treatment of Schizophrenia.

28. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy.

29. Frequency and Correlates of Inappropriate Pediatric Psychiatric Emergency Room Visits.

30. Elevated Cardiovascular Risk in Patients With Bipolar Disorder: When Does It Start and Where Does It Lead?

37. Second-Generation Antipsychotic-Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need.

38. The Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia: A Targeted Literature Review With a Focus on Outcomes Relevant to Health Care Decision-Makers in the United States.

39. The Clinician's Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive Dyskinesia.

41. Magnitude and Correlates of Symptomatic, Global Illness, and Social Functioning Response; Out-of-Home Placement; and Length of Stay in 1,189 Consecutively Hospitalized Children and Adolescents With Mental Disorders.

42. Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: Results of the Randomized, Controlled ENLIGHTEN-Early Study.

43. Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder.

44. Reasons for Antipsychotic Treatment Switch: A Systematic Retrospective Review of Prescription Records and Prescriber Notes.

45. Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia.

46. Patient Functioning and Life Engagement: Unmet Needs in Major Depressive Disorder and Schizophrenia.

47. Effects of Brexpiprazole on Functioning in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies.

48. Emerging Treatments in Schizophrenia.

49. Diagnostic and Treatment Fundamentals for Tardive Dyskinesia.

50. Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options.

Catalog

Books, media, physical & digital resources